
### [Orphanet:166484](http://www.orpha.net/ORDO/Orphanet_166484)
**Label:** Inflammatory and autoimmune disease with epilepsy

**Subclasses:** [Orphanet:1459](http://www.orpha.net/ORDO/Orphanet_1459) (Celiac disease-epilepsy-cerebral calcification syndrome), [Orphanet:1214](http://www.orpha.net/ORDO/Orphanet_1214) (Progressive hemifacial atrophy), [Orphanet:900](http://www.orpha.net/ORDO/Orphanet_900) (Granulomatosis with polyangiitis), [Orphanet:117](http://www.orpha.net/ORDO/Orphanet_117) (Beh√ßet disease), [Orphanet:797](http://www.orpha.net/ORDO/Orphanet_797) (Sarcoidosis), 

**Corr. equiv. classes:** [OMIM:109650](http://purl.obolibrary.org/obo/OMIM_109650), [OMIM:612387](http://purl.obolibrary.org/obo/OMIM_612387), [OMIM:612388](http://purl.obolibrary.org/obo/OMIM_612388), [OMIM:181000](http://purl.obolibrary.org/obo/OMIM_181000), [OMIM:608710](http://purl.obolibrary.org/obo/OMIM_608710), [OMIM:226810](http://purl.obolibrary.org/obo/OMIM_226810), [Orphanet:900](http://www.orpha.net/ORDO/Orphanet_900), [Orphanet:1459](http://www.orpha.net/ORDO/Orphanet_1459), [Orphanet:797](http://www.orpha.net/ORDO/Orphanet_797), [Orphanet:117](http://www.orpha.net/ORDO/Orphanet_117), [OMIM:141300](http://purl.obolibrary.org/obo/OMIM_141300), [Orphanet:1214](http://www.orpha.net/ORDO/Orphanet_1214), 

**Class expressions from DL-Learner:**

- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) and [HP:0100533](http://purl.obolibrary.org/obo/HP_0100533) (Inflammatory abnormality of the eye) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) and [HP:0025032](http://purl.obolibrary.org/obo/HP_0025032) (Abnormality of digestive system physiology) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0012378](http://purl.obolibrary.org/obo/HP_0012378) (Fatigue) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0012373](http://purl.obolibrary.org/obo/HP_0012373) (Abnormal eye physiology) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0012243](http://purl.obolibrary.org/obo/HP_0012243) (Abnormal reproductive system morphology) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0011355](http://purl.obolibrary.org/obo/HP_0011355) (Localized skin lesion) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0011123](http://purl.obolibrary.org/obo/HP_0011123) (Inflammatory abnormality of the skin) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0011122](http://purl.obolibrary.org/obo/HP_0011122) (Abnormality of skin physiology) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0011032](http://purl.obolibrary.org/obo/HP_0011032) (Abnormality of fluid regulation) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0011024](http://purl.obolibrary.org/obo/HP_0011024) (Abnormality of the gastrointestinal tract) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0009830](http://purl.obolibrary.org/obo/HP_0009830) (Peripheral neuropathy) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0006824](http://purl.obolibrary.org/obo/HP_0006824) (Cranial nerve paralysis) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%
- [HP:0002105](http://purl.obolibrary.org/obo/HP_0002105) (Hemoptysis) and [HP:0004325](http://purl.obolibrary.org/obo/HP_0004325) (Decreased body weight) and [HP:0012575](http://purl.obolibrary.org/obo/HP_0012575) (Abnormality of the nephron) 62.50%


